China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China
· Delayed Price · Currency is CNY 17.72
+0.15 (0.85%)
Apr 29, 2026, 3:04 PM CST
SHE:300294 Revenue
China Resources Boya Bio-pharmaceutical Group Co.,Ltd had revenue of 321.13M CNY in the quarter ending March 31, 2026, a decrease of -40.07%. This brings the company's revenue in the last twelve months to 1.84B, up 1.21% year-over-year. In the year 2025, China Resources Boya Bio-pharmaceutical Group Co.,Ltd had annual revenue of 2.06B with 18.69% growth.
Revenue (ttm)
1.84B
Revenue Growth
+1.21%
P/S Ratio
4.80
Revenue / Employee
947.27K
Employees
1,947
Market Cap
8.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.06B | 324.18M | 18.69% |
| Dec 31, 2024 | 1.73B | -917.08M | -34.58% |
| Dec 31, 2023 | 2.65B | -106.72M | -3.87% |
| Dec 31, 2022 | 2.76B | 108.17M | 4.08% |
| Dec 31, 2021 | 2.65B | 137.49M | 5.47% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Medicilon | 1.16B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 1.94B |
| Sino Biological,Inc. | 699.56M |
| Bio-Thera Solutions | 935.22M |
| Youcare Pharmaceutical Group | 2.45B |
| Aurisco Pharmaceutical | 1.68B |
| Liaoning Chengda Biotechnology | 1.39B |
| Beijing Hotgen Biotech | 404.88M |